BioSpace News Archive

GB Sciences, Inc. announced that Dr. Dominick Monaco, GB Sciences’ Director of Medical Formulations, will be a featured speaker at the Las Vegas Cannabis Conference, April 2, at 4:40pm.

Leading Men’s Health Charity Survey Shows More Than Half of Young Men Unaware of Risk

New Protocol Creator Software Brings Treatments to Market Faster

Bicycle Therapeutics announced that Bicycle scientists have been selected to present two oral presentations at the American Association for Cancer Research Annual Meeting in Atlanta.

Co-Diagnostics, Inc., a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, announced the filing of their financial results for FY 2018, ending December 31, 2018, as well as updates on the Company’s growth and progress for 2018 in the following areas

Merck, known as MSD outside the United States and Canada, announced the successful completion of the cash tender offer, through a subsidiary, for all of the outstanding shares of common stock of Immune Design at a purchase price of $5.85 per share.

Previously reported positive Phase 3 results demonstrated the potential for abicipar to be the first anti-VEGF therapy to maintain initial vision gains in all patients on a true fixed 12-week dosing interval

ITM Isotopen Technologien München AG and United Imaging Healthcare Co., Ltd. announced that they have signed an agreement to collaborate in marketing and sales of ITM and UIH imaging and related products to clinical customers in China and worldwide.

Many small and mid-sized business owners are overwhelmed with administrative HR tasks.

C3J’s pending merger with AmpliPhi Biosciences, which will create a clinical-stage phage leader, is on track to close in May 2019